… After over 30 years of theorizing, the use of angiogenesis inhibitors as anticancer therapy
has … makes them attractive therapeutic targets. A multitude of VEGF-targeted inhibitory agents …

… This is an essential prerequisite for exosomes to be applied for targeted cancer therapy
because target orientation-related molecules from parent cells are also present in exosomes [8]. …

… Targeted therapeutic approaches are therefore preferred, … of highly-effective targeted therapies
with minimal side effects. … already demonstrated its potential for targeted cancer therapy. …

… Therefore, a comprehensive understanding of ECM dysregulation in the TME would
contribute to the discovery of promising therapeutic targets for cancer treatment. Herein, we …

… targets that determine therapeutic outcome. The molecularly targeted cancer therapies
have resulted in improving the lives of a large number of cancer patients. The successful …

… of the drug until it reaches its target. Conversely, many unconjugated antibodies are highly
specific for a cancer target, but have low therapeutic potential and can be repurposed as …

… of selectivity in targeting tumor cells. Moreover, … drugs into targeted cells. As of January
1996, there were approximately 80 agents (excluding mAbs) approved for the treatment of cancer…

… of targeted cancer treatment therapies. Although various targeted cancer treatment drugs …
usually specific types of cancers for which each of the drugs will be therapeutically efficacious. …

… ligand for targeted cancer therapies because it binds to a tumor-… to therapeutic agents,
folate-targeted cancer therapies can deliver therapeutic drugs specifically to FR-positive tumor …

… in anticancer drug development. Nevertheless, molecularly targeted cancer therapy remains
… and remaining challenges in molecularly targeted cancer therapy, and proposes feasible …